Q1 revenues slide for Amgen, Gilead

Amgen and Gilead Sciences released their respective Q1 2023 earnings reports Thursday afternoon.

Amgen’s total revenues decreased 2% to $6.1 billion due in part to lower other revenue from the company’s COVID-19 manufacturing collaboration.